Authors:
CHERNEW ME
HIRTH RA
SONNAD SS
ERMANN R
FENDRICK AM
Citation: Me. Chernew et al., MANAGED CARE, MEDICAL TECHNOLOGY, AND HEALTH-CARE COST GROWTH - A REVIEW OF THE EVIDENCE, Medical care research and review, 55(3), 1998, pp. 259-288
Authors:
HIRTH RA
CHERNEW ME
MILLER E
FENDRICK AM
WEISSERT WG
Citation: Ra. Hirth et al., AT SHOULD SOCIETY BE WILLING TO PAY FOR A QALY - EVIDENCE FROM THE VALUE LIFE LITERATURE, Medical decision making, 18(4), 1998, pp. 459-459
Authors:
CHUNG RC
WALTERS MR
GREENFIELD MLVH
CHERNEW ME
Citation: Rc. Chung et al., ENDOSCOPIC VERSUS OPEN CARPAL-TUNNEL RELEASE - A COST-EFFECTIVENESS ANALYSIS, Plastic and reconstructive surgery, 102(4), 1998, pp. 1089-1099
Authors:
FENDRICK AM
BANDEKAR R
CHERNEW ME
SCHEIMAN JM
Citation: Am. Fendrick et al., IMPACT OF NSAID CHOICE AND PATIENT SYMPTOMS ON THE COST-EFFECTIVENESSOF STRATEGIES TO PREVENT NSAID GASTROPATHY, Gastroenterology, 114(4), 1998, pp. 492-492
Authors:
SCHEIMAN JM
BANDEKAR RR
CHERNEW ME
FENDRICK AM
Citation: Jm. Scheiman et al., SHOULD PATIENTS REQUIRING CHRONIC NSAID THERAPY BE SCREENED FROM HELICOBACTER-PYLORI, Arthritis and rheumatism, 41(9), 1998, pp. 259-259
Authors:
FENDRICK AM
MCCORT JT
CHERNEW ME
HIRTH RA
PATEL C
BLOOM BS
Citation: Am. Fendrick et al., IMMEDIATE ERADICATION OF HELICOBACTER-PYLORI IN PATIENTS WITH PREVIOUSLY DOCUMENTED PEPTIC-ULCER DISEASE - CLINICAL AND ECONOMIC-EFFECTS, The American journal of gastroenterology, 92(11), 1997, pp. 2017-2024
Authors:
HIRTH RA
CHERNEW ME
CARROLL C
ARMSTRONG S
Citation: Ra. Hirth et al., MEDICARE REIMBURSEMENT AND THE UTILIZATION OF EPO IN 1989 AND 1993, Journal of the American Society of Nephrology, 7(9), 1996, pp. 711-711
Authors:
HIRTH RA
CHERNEW ME
CARROLL C
ARMSTRONG S
Citation: Ra. Hirth et al., DIALYSIS TECHNOLOGIES AND PRACTICES IN A FIXED REIMBURSEMENT ENVIRONMENT, Journal of the American Society of Nephrology, 7(9), 1996, pp. 1003-1003
Citation: Bs. Bloom et al., CLINICAL AND ECONOMIC-EFFECTS OF MUPIROCIN CALCIUM ON PREVENTING STAPHYLOCOCCUS-AUREUS INFECTION IN HEMODIALYSIS-PATIENTS - A DECISION-ANALYSIS, American journal of kidney diseases, 27(5), 1996, pp. 687-694
Citation: Am. Fendrick et al., IMMEDIATE ENDOSCOPY OR INITIAL HELICOBACTER-PYLORI SEROLOGICAL TESTING FOR SUSPECTED PEPTIC-ULCER DISEASE - ESTIMATING COST-EFFECTIVENESS USING DECISION-ANALYSIS, The Yale journal of biology & medicine, 69(2), 1996, pp. 187-195
Citation: Ra. Hirth et al., SPECIALIST AND GENERALIST PHYSICIANS ADOPTION OF ANTIBIOTIC-THERAPY TO ERADICATE HELICOBACTER-PYLORI INFECTION, Medical care, 34(12), 1996, pp. 1199-1204
Authors:
OLSON AD
FENDRICK AM
DEUTSCH D
CHERNEW ME
HIRTH RA
PATEL C
BLOOM BS
Citation: Ad. Olson et al., EVALUATION OF INITIAL NONINVASIVE THERAPY IN PEDIATRIC-PATIENTS PRESENTING WITH SUSPECTED ULCER DISEASE, Gastrointestinal endoscopy, 44(5), 1996, pp. 554-561
Citation: Am. Fendrick et al., DIFFERENCES BETWEEN GENERALIST AND SPECIALIST PHYSICIANS REGARDING HELICOBACTER-PYLORI AND PEPTIC-ULCER DISEASE, The American journal of gastroenterology, 91(8), 1996, pp. 1544-1548
Authors:
OLSON AD
DEUTSCH D
LOUISJACQUES O
FENDRICK AM
CHERNEW ME
HIRTH RA
BLOOM BS
Citation: Ad. Olson et al., CLINICAL AND ECONOMIC-ANALYSIS OF IMMEDIATE ENDOSCOPY, SEROLOGICAL SCREENING FOR HELICOBACTER-PYLORI AND EMPIRIC TREATMENT OF HELICOBACTER-PYLORI FOR PEDIATRIC-PATIENTS WITH DYSPEPSIA, Gastrointestinal endoscopy, 41(4), 1995, pp. 341-341
Citation: Am. Fendrick et al., ALTERNATIVE TREATMENT STRATEGIES FOR PATIENTS WITH DYSPEPSIA IN THE HELICOBACTER-PYLORI ERA, Gastroenterology, 108(4), 1995, pp. 13-13
Citation: Am. Fendrick et al., ALTERNATIVE MANAGEMENT STRATEGIES FOR PATIENTS WITH SUSPECTED PEPTIC-ULCER DISEASE, Annals of internal medicine, 123(4), 1995, pp. 260-268